LISA NUTT: Open Payments
NPI 1861734329 · WOODBURY, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,105 in 66 payments from 14 companies in 2025. Trend: 2023 $300 · 2024 $1,408 · 2025 $1,105
Food & beverage: $1,105
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $257 |
| Novo Nordisk Inc | 14 | $254 |
| AstraZeneca Pharmaceuticals LP | 8 | $147 |
| Astellas Pharma US Inc | 4 | $72 |
| PFIZER INC. | 4 | $69 |
| Lilly USA, LLC | 3 | $52 |
| Amgen Inc. | 3 | $52 |
| Phathom Pharmaceuticals, Inc. | 3 | $45 |
| SANOFI-AVENTIS U.S. LLC | 2 | $40 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $36 |
Products named: Ozempic, VRAYLAR, Rybelsus, FARXIGA, Veozah, UBRELVY, QULIPTA, PREVNAR 20.
Industry payments across NJ — which companies pay providers there.
